130 likes | 391 Views
Drug device combination products are defined as the individual products comprising of two regulated components, an active pharmaceutical ingredient and medical device that are chemically or physically combined to produce a single product. The drugs present in the device are either impregnated or surface coated. Combination products have emerged as innovative medical products due to their contribution in advancing medical care and are thus expected to have major impact on the overall medical devices market.
E N D
TransparencyMarketResearch DrugDeviceCombinationProductsMarket-GlobalIndustryAnalysis, Size,Share,Growth,TrendsandForecast2013-2019 PublishedDate 24-Dec-2013 117PageReport RequestSample BuyNow PressRelease TheGlobalDrugDeviceCombinationProductsMarkettoGrowat7.9% CAGRbetween2013and2019 TransparencyMarketResearch StateTower, 90,StateStreet,Suite700. Albany,NY12207 UnitedStates www.transparencymarketresearch.com sales@transparencymarketresearch.com
REPORTDESCRIPTION DrugDeviceCombinationProductsMarket-GlobalIndustryAnalysis,Size,Share,Growth, TrendsandForecast2013-2019 Drugdevicecombinationproductsaredefinedastheindividualproductscomprisingoftworegulated components,anactivepharmaceuticalingredientandmedicaldevicethatarechemicallyorphysically combinedtoproduceasingleproduct.Thedrugspresentinthedeviceareeitherimpregnatedor surfacecoated.Combinationproductshaveemergedasinnovativemedicalproductsduetotheir contributioninadvancingmedicalcareandarethusexpectedtohavemajorimpactontheoverall medicaldevicesmarket. BrowseDrugDeviceCombinationProductsMarketreport: http://www.transparencymarketresearch.com/drug-device-combination.html Thisreportcoversthemarketanalysisforvariousdrugdevicecombinationproductsfromthe perspectiveofproducttypes.Thestakeholdersforthisreportincludethepresentmanufacturersand providersofdrugdevicecombinationproductsaswellasthenewplayerswhodesiretoenterthis market.Thisreportcomprisesanexecutivesummary,whichprovidesthemarketsnapshotcovering overallinformationaboutthevarioussegmentsandsub-segmentsofdrugdevicecombination productsmarket. Themarketoverviewsectionofthereportexplainsaboutthemarketdynamicsandtrendssuchas thedrivers,restraintsandopportunitiesthathaveaninfluenceovercurrentandfuturestatusofthis market.DegreeofcompetitivenessisexplainedthroughPorter’sfiveforcesanalysisandthemost attractiveregionalmarketbytypeisrepresentedinthemarketattractivenessanalysissectionofthis report.Allthesefactorswillhelpthemarketplayerstodecideaboutthebusinessstrategiesandplans tobeincurredinfutureforstrengtheningtheirpositionintheglobalmarket. BrowseRequestreport:http://www.transparencymarketresearch.com/sample/sample.php? flag=S&rep_id=1534 Theglobaldrugdevicecombinationproductsmarkethasbeendifferentiatedintoeightsegments basedontheproducttypes.Theproductsanalyzedinthisstudyarethedrugelutingstents,infusion pumps,bonegraftimplants,photodynamictherapy,woundcarecombinationdevices,inhalers, transdermalpatchesandothers(intraoralimplantsanddrugelutingbeads).Dependingontypes, theseproductsarefurtherdifferentiatedintosubsegments.Drugelutingstentshasbeensegmented intocoronarystentsandperipheralvascularstents.Orthopediccombinationproductsmarketincludes twosubsegmentsnamelyantibioticbonecementandbonegraftimplants.Infusionpumpshasbeen segmentedintoimplantableinfusionpumpsandambulatoryinfusionpumps.Inhalersmarketis furtherclassifiedintothreesegmentsnamelynebulizers,metereddoseinhalersanddrypowder inhalers.Eachoftheaboveproductsegmentsandsub-segmentsareanalyzedonthebasisofmarket TransparencyMarketResearch
sizeintermsofUSDmillionfortheperiod2011-2019alongwithcompoundedannualgrowthratesizeintermsofUSDmillionfortheperiod2011-2019alongwithcompoundedannualgrowthrate (CAGR%)fortheperiod,considering2012asthebaseyear. BrowseDrugDeviceCombinationProductsMarketpressrelease: http://www.transparencymarketresearch.com/pressrelease/drug-device-combination.htm Geographically,thedrugdevicecombinationproductsmarkethasbeenclassifiedintofourmajor segmentsnamely,NorthAmerica,Europe,AsiaPacificandRestoftheWorld.Marketrevenuefor 2011to2012andforecastfor2013to2019fordrugdevicecombinationproductsisanalyzedinthis report.ThissectionalsoprovidestheCAGR%ofeachgeographicalregionfortheforecastperiodof 2013to2019.Acompetitivelandscape,mappingallthemarketplayersandtheirrespectivemarket sharesfor2012areprovidedinthisreportfordrugelutingstentsandinfusionpumps.Alist ofrecommendationsisalsoprovidedinthisreporttohelpmarketplayersinincreasingtheir marketshareandnewentrantsinestablishingtheirstrongpositioninthemarket. Thereportconcludeswiththecompanyprofilesectionwhichcoversthekeyinformationsuchas companyoverview,financialoverview,productportfolio,businessstrategiesandrecentdevelopments aboutthemajormarketplayersinthedrugdevicecombinationproducts.Someofthemajor companieswhichareprofiledinthisreportincludeAbbottLaboratories,Allergan,Inc.,Alcon,Inc., ArrowInternational,Inc.,BostonScientificCorporation,CareFusionCorporation,CovidienPLC,C.R. Bard,Inc.,Ethicon,Inc.,MedlineIndustries,Inc.,Medtronic,Inc.,Mylan,Inc.,PinnacleBiologics,Inc., StrykerCorporation,TerumoCorporation,W.L.Gore&Associates,Inc. TABLEOFCONTENT Chapter1Introduction 1.1ReportDescription 1.2MarketSegmentation 1.3ResearchMethodology 1.3.1SecondaryResearch 1.3.2PrimaryResearch 1.3.3StatisticalModels 1.3.4ListofAbbreviations 1.3.5AssumptionsandStipulations TransparencyMarketResearch
Chapter2ExecutiveSummary Chapter3MarketOverview 3.1MarketDefinitionandOverview 3.2MarketDrivers 3.2.1Riseinagingpopulationandconsequentcasesofchronicdiseasesworldwide 3.2.2Increasingdemandforminimallyinvasiveproducts 3.3MarketRestraints 3.3.1Infectionsfromdrugdevicecombinationproductssuchasimplantsandassociatedproductrecalls 3.4MarketOpportunities 3.4.1Growthopportunitiesinemergingeconomieswithhighunmetneeds 3.4.2Introductionofbiodegradabletechnologybasedproducts 3.5Porter’sFiveForcesAnalysis:GlobalDrugDeviceCombinationProductsMarket 3.5.1BargainingPowerofSuppliers 3.5.2BargainingPowerofBuyers 3.5.3ThreatofSubstitutes 3.5.4ThreatofNewEntrants 3.5.5CompetitiveRivalry 3.6MarketAttractivenessAnalysis:GlobalDrugDeviceCombinationProductsMarket,byTypes BrowseDrugDeviceCombinationProductsMarketreport: http://www.transparencymarketresearch.com/drug-device-combination.html Chapter4GlobalDrugDeviceCombinationProducts,byType,SizeandForecast,2011-2019(USD Billion) 4.1Introduction 4.1.1GlobalDrugDeviceCombinationProductsMarketRevenue,2011-2019(USDBillion) TransparencyMarketResearch
4.2DrugElutingStents 4.2.1GlobalDrugElutingStentsMarketRevenue,2011-2019(USDBillion) 4.2.2CoronaryStents 4.2.2.1GlobalCoronaryDrugElutingStentsMarket,2011-2019(USDBillion) 4.2.3PeripheralVascularStents 4.2.3.1GlobalPeripheralVascularDrugElutingStentsMarket,2011-2019(USDBillion) 4.3InfusionPumps 4.3.1GlobalInfusionPumpsMarketRevenue,2011-2019(USDBillion) 4.3.2ImplantableInfusionPumps 4.3.2.1GlobalImplantableInfusionPumpsMarketRevenue,2011-2019(USDBillion) 4.3.3AmbulatoryInfusionPumps 4.3.4GlobalAmbulatoryInfusionPumpsMarketRevenue,2011-2019(USDBillion) 4.4Photosensitizers 4.4.1GlobalPhotosensitizersMarketRevenue,2011-2019(USDBillion) BrowseRequestreport:http://www.transparencymarketresearch.com/sample/sample.php? flag=S&rep_id=1534 4.5OrthopedicCombinationProducts 4.5.1GlobalOrthopedicCombinationProductsMarketRevenue,2011-2019(USDBillion) 4.5.2AntibioticBoneCement 4.5.3BoneGraftImplants 4.6WoundCareCombinationProducts 4.6.1AntibioticWoundCareProducts 4.6.2GlobalWoundCareCombinationProductsMarketRevenue,2011-2019(USDBillion) TransparencyMarketResearch
4.7Inhalers 4.7.1GlobalInhalersMarketRevenue,2011-2019(USDBillion) 4.7.2Nebulizers 4.7.2.1GlobalNebulizersMarketRevenue,2011-2019(USDBillion) 4.7.3MeteredDoseInhalers 4.7.3.1GlobalMeteredDoseInhalersMarketRevenue,2011-2019(USDBillion) 4.7.4DryPowderInhalers 4.7.4.1GlobalDryPowderInhalersMarketRevenue,2011-2019(USDBillion) 4.8TransdermalPatches 4.8.1GlobalTransdermalPatchesMarketRevenue,2011-2019(USDBillion) 4.9OtherDrugDeviceCombinationProducts 4.9.1GlobalOtherDrugDeviceCombinationProductsMarketRevenue,2011-2019(USDBillion) 4.9.2IntraocularImplants 4.9.3DrugElutingBeads BrowseDrugDeviceCombinationProductsMarketpressrelease: http://www.transparencymarketresearch.com/pressrelease/drug-device-combination.htm Chapter5GlobalDrugDeviceCombinationProducts,byGeography,2011-2019(USDMillion) 5.1Overview 5.1.1GlobalDrugDeviceCombinationProductsMarket,byGeography,2011-2019(USDBillion) 5.1.2GlobalDrugDeviceCombinationProductsMarket,byGeography,2012and2019(%) 5.2NorthAmerica 5.2.1NorthAmericaDrugDeviceCombinationProductsMarketRevenue,2011–2019(USDBillion) 5.3Europe TransparencyMarketResearch
5.3.1EuropeDrugDeviceCombinationProductsMarketRevenue,2011–2019(USDBillion)5.3.1EuropeDrugDeviceCombinationProductsMarketRevenue,2011–2019(USDBillion) 5.4Asia-Pacific 5.4.1Asia-PacificDrugDeviceCombinationProductsMarketRevenue,2011–2019(USDBillion) 5.5RestoftheWorld 5.5.1RoWDrugDeviceCombinationProductsMarketRevenue,2011–2019(USDBillion) Chapter6CompetitiveLandscape 6.1MarketShareAnalysis:GlobalDrugDeviceCombinationProductsMarket 6.1.1Methodology 6.1.2MarketShareAnalysisfortheglobaldrugelutingstentsmarket,bykeyplayers,2012 6.1.3Marketshareanalysisfortheglobalinfusionpumpsmarket,bykeyplayers,2012 BrowseDrugDeviceCombinationProductsMarketreport: http://www.transparencymarketresearch.com/drug-device-combination.html Chapter7Recommendations 7.1ResearchandDevelopmentInitiatives 7.2ConvergingTechnologiestoYieldEfficiencies 7.3MergersandAcquisitionstoImproveMarketPresence 7.4ConductingProductAwarenessPrograms 7.5InvestinginEmergingEconomies Chapter8CompanyProfiles 8.1AbbottLaboratories 8.1.1CompanyOverview 8.1.2FinancialOverview 8.1.3ProductPortfolio TransparencyMarketResearch
8.1.4BusinessStrategies 8.1.5RecentDevelopments 8.2Allergan,Inc. 8.2.1CompanyOverview 8.2.2FinancialOverview 8.2.3ProductPortfolio 8.2.4RecentDevelopments 8.2.5BusinessStrategies 8.3Alcon,Inc. 8.3.1CompanyOverview 8.3.2FinancialOverview 8.3.3ProductPortfolio 8.3.4BusinessStrategies 8.3.5RecentDevelopment BrowseRequestreport:http://www.transparencymarketresearch.com/sample/sample.php? flag=S&rep_id=1534 8.4ArrowInternational,Inc. 8.4.1CompanyOverview 8.4.2FinancialOverview 8.4.3ProductPortfolio 8.4.4BusinessStrategies 8.4.5RecentDevelopments 8.5Bausch&Lomb,Inc. TransparencyMarketResearch
8.5.1CompanyOverview 8.5.2FinancialOverview 8.5.3ProductPortfolio 8.5.4RecentDevelopments 8.5.5BusinessStrategies 8.6BostonScientificCorporation 8.6.1CompanyOverview 8.6.2FinancialOverview 8.6.3ProductPortfolio 8.6.4BusinessStrategies 8.6.4.1Acquisitions 8.6.5RecentDevelopments BrowseDrugDeviceCombinationProductsMarketpressrelease: http://www.transparencymarketresearch.com/pressrelease/drug-device-combination.htm 8.7CareFusionCorporation 8.7.1CompanyOverview 8.7.2FinancialOverview 8.7.3ProductPortfolio 8.7.4BusinessStrategies 8.7.5RecentDevelopments 8.8CovidienPLC 8.8.1CompanyOverview 8.8.2FinancialOverview TransparencyMarketResearch
8.8.3ProductPortfolio 8.8.4BusinessStrategies 8.8.5RecentDevelopments 8.9C.R.Bard,Inc. 8.9.1CompanyOverview 8.9.2FinancialOverview 8.9.3ProductPortfolio 8.9.4BusinessStrategies 8.9.5RecentDevelopments 8.10Ethicon,Inc. 8.10.1CompanyOverview 8.10.2FinancialOverview 8.10.3ProductPortfolio 8.10.4BusinessStrategies 8.10.5RecentDevelopments BrowseDrugDeviceCombinationProductsMarketreport: http://www.transparencymarketresearch.com/drug-device-combination.html 8.11MedlineIndustries,Inc. 8.11.1CompanyOverview 8.11.2FinancialOverview 8.11.3ProductPortfolio 8.11.4BusinessStrategies 8.11.5RecentDevelopments TransparencyMarketResearch
8.12Medtronic,Inc. 8.12.1CompanyOverview 8.12.2FinancialOverview 8.12.3ProductPortfolio 8.12.4BusinessStrategies 8.12.5RecentDevelopment 8.13Mylan,Inc. 8.13.1CompanyOverview 8.13.2FinancialOverview 8.13.3ProductPortfolio 8.13.4BusinessStrategies 8.13.5RecentDevelopments 8.14PinnacleBiologics,Inc. 8.14.1CompanyOverview 8.14.2FinancialOverview 8.14.3ProductPortfolio 8.14.4BusinessStrategies 8.14.5RecentDevelopments BrowseRequestreport:http://www.transparencymarketresearch.com/sample/sample.php? flag=S&rep_id=1534 8.15StrykerCorporation 8.15.1CompanyOverview 8.15.2FinancialOverview TransparencyMarketResearch
8.15.3ProductPortfolio 8.15.4BusinessStrategies 8.16TerumoCorporation 8.16.1CompanyOverview 8.16.2FinancialOverview 8.16.3ProductPortfolio 8.16.4BusinessStrategies 8.16.5RecentDevelopment BrowseDrugDeviceCombinationProductsMarketpressrelease: http://www.transparencymarketresearch.com/pressrelease/drug-device-combination.htm 8.17W.L.Gore&Associates,Inc. 8.17.1CompanyOverview 8.17.2FinancialOverview 8.17.3ProductPortfolio 8.17.4RecentDevelopments AboutUs TransparencyMarketResearchisamarketintelligencecompanyprovidingglobalbusinessinformationreports andservices.Ourexclusiveblendofquantitativeforecastingandtrendsanalysisprovidesforward-lookinginsightforthousandsofdecisionmakers. WeareprivilegedwithhighlyexperiencedteamofAnalysts,ResearchersandConsultants,whouse proprietarydatasourcesandvarioustoolsandtechniquestogather,andanalyzeinformation.Ourbusinessofferingsrepresentthelatestandthemostreliableinformationindispensableforbusinessestosustainacompetitiveedge. TransparencyMarketResearch
Contact TransparencyMarketResearch 90StateStreet,Suite700,Albany NY-12207 UnitedStates Tel:+1-518-618-1030 USA-CanadaTollFree866-552-3453 Email:sales@transparencymarketresearch.com Website:http://www.transparencymarketresearch.com/ TransparencyMarketResearch